2026-TXG-JPM-Healthcare-Presentation-01-12-2026.pdf

1、44th Annual J.P.Morgan Healthcare ConferenceSerge SaxonovCEO and Co-founderJanuary 12,2026 10X GENOMICS,INC.20262 2Certain statements in this presentation and the accompanying oral commentary are“forward-looking statements”within the meaning of the Private Securities LitigationReform Act of 1995 as

2、contained in Section 27A of the Securities Act of 1933,as amended,and Section 21E of the Securities Exchange Act of 1934,as amended,which are subject to the“safe harbor”created by those sections.All statements,other than statements of historical facts,may be forward-looking statements.Forward-lookin

3、g statements generally can be identified by the use of forward-looking terminology such as“may,”“might,”“will,”“should,”“expect,”“plan,”“anticipate,”“could,”“intend,”“target,”“project,”“contemplate,”“believe,”“see,”“estimate,”“predict,”“potential,”“would,”“likely,”“seek”or“continue”or the negatives

4、of these terms orvariations of them or similar terminology,but the absence of these words does not mean that a statement is not forward-looking.These forward-looking statementsinclude statements regarding 10 x Genomics,Inc.s expected financial results,operations,the features,performance,capabilities

5、,uses,costs,demand,opportunities,growth,drivers and adoption of current and potential future solutions,plans and expectations regarding entering the clinical and diagnostic markets,the timing andoutcome of regulatory filings and approvals,as well as product roadmap,expected development directions an

6、d expected release of potential products.Thesestatements are based on managements current expectations,forecasts,beliefs,assumptions and information currently available.Actual outcomes and results coulddiffer materially from these statements due to a number of factors and such statements should not